Crossmark

Photobiomodulation therapy in the management of oral mucositis: search for the optimal clinical treatment parameters

Crossref DOI link: https://doi.org/10.1007/s00520-018-4262-6

Published Online: 2018-05-22

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elad, Sharon

Arany, Praveen

Bensadoun, Rene-Jean

Epstein, Joel B.

Barasch, Andrei

Raber-Durlacher, Judith
License Information

Text and Data Mining valid from 2018-05-22
More Information

Article History

Received: 13 January 2018

Accepted: 10 May 2018

First Online: 22 May 2018

Compliance with ethical standards

:

: The study is not funded. The following author disclosed relationship to commercial companies: PA (consultation to Lumitex, Philips Research Labs, RogerSciences International; patents at Harvard University; travel expenses covered by Lumithera, Thor lasers, Weber Medical). The following authors disclosed no conflict of interest: SE, R-JB, JE, JR-D, and AB. The authors have full control of all primary data and agree to allow the journal to review their data if requested.